Skip to content

The effects of Mallow in the treatment of asthma

The evaluation of the aqueous extract of Malva Sylvesteris, in the treatment of mild to severe adult asthmatic patients in comparison with placebo group; randomized double-blind study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014082318899N1
Enrollment
100
Registered
2014-11-30
Start date
2014-10-07
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. chronic obstructive asthma

Interventions

Intervention 1: Intervention 2 in control group: placebo including capsules contain sucrose twice a day for 1 month by oral route. Intervention 2: Intervention 1: aqueous extract of Malva Sylvestris a
Treatment - Drugs
Intervention 2 in control group: placebo including capsules contain sucrose twice a day for 1 month by oral route
Intervention 1: aqueous extract of Malva Sylvestris at doses of 600 mg/day (300 mg twice a day by oral route for 1 month)

Sponsors

Deputy for research of Bushehr University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 15-65 years, minimum 6 months with mild to severe asthma, non-seasonal asthma and non-smoker Exclusion criteria: respiratory infection, immunologic and neurological disorders, pregnancy, history of myocardial infarction, chronic obstructive pulmonary disorder and diabetes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Forced expiratory volume at first second (FEV1). Timepoint: Before, 1 month and 3 months after treatment. Method of measurement: Pulmonary function test by spirometry.

Secondary

MeasureTime frame
Adverse effects of Malva Sylvestris extract. Timepoint: 1 and 3 months after treatment. Method of measurement: Questionnaire and pulmonary function test using spirometry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojtaba Keshavarz

Bushehr University of Medical Sciences

moj.ph60@yahoo.commkeshavar80@gmail.com+98 77 1252 4044

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026